Swaraj Suiting Ltd has announced a major fundraising plan through a preferential issue of equity shares and warrants. The company intends to raise Rs 174.2 crore from non-promoter investors to support working capital, facility modernization, and manufacturing expansion. The proposal will be put to a vote at an Extraordinary General Meeting (EGM) on October 24, 2026. This capital injection is aimed at scaling operations, though investors should account for the resulting equity dilution and the 18-month timeline for warrant conversion.
Swaraj Suiting to Raise Rs 174.2 Crore via Preferential Issue
Swaraj Suiting is raising Rs 174.2 crore through a preferential issuance of equity shares and warrants.
The company plans to issue 35 lakh shares and 17 lakh warrants at an issue price of Rs 335 each.
Reader Takeaway: The capital infusion boosts growth potential but introduces equity dilution for existing shareholders to monitor closely.
What just happened
Swaraj Suiting Ltd has called for an Extraordinary General Meeting (EGM) on October 24, 2026, to seek shareholder approval for a significant fundraise. The company intends to issue 35,00,000 equity shares to raise Rs 117.25 crore and 17,00,000 convertible warrants to raise an additional Rs 56.95 crore. The issue price of Rs 335 per instrument is set above the SEBI-mandated floor price of Rs 330.04.
Why this matters
The fundraising is earmarked for strategic growth. Proceeds will cover incremental working capital requirements and significant capital expenditure, including the installation of new manufacturing lines and modernization of existing infrastructure. By appointing CRISIL Ratings as a monitoring agency, the company aims to ensure transparency in how these funds are deployed.
What changes now
Following the allotment, the public shareholding composition of the company will change, as the issuance is directed toward non-promoter entities. Investors should note that the warrants have an 18-month conversion window. If not converted within this period, the warrants will lapse and the premium paid will be forfeited. Equity shares issued will be subject to a six-month lock-in period, while warrants will face a one-year lock-in.
Risks to watch
The primary risk for retail investors is the dilution of earnings per share resulting from the issuance of new equity. Additionally, the company's ability to successfully scale its manufacturing capacity and derive returns from this capital expenditure remains a key operational test to watch over the next few years.
What to track next
Shareholders should monitor the outcomes of the EGM vote on October 24 and subsequent filings regarding the actual allotment of shares and warrants. Future quarterly results should be audited against the stated goal of using these funds for business growth and modernization.